Skip to main content
Premium Trial:

Request an Annual Quote

Congenica Inks French Distribution Deal With AmpliTech

NEW YORK – Congenica said Monday that it has entered into a distribution agreement with Amplitech to distribute its products in France and other French-speaking European countries.

AmpliTech, based in Compiègne, France, will distribute Congenica's clinical decision support platform, allowing the Cambridge, UK-based firm to enter the French market for the first time.

AmpliTech distributes software and instruments for in vitro diagnostics and research to hospitals and laboratories in France, Belgium, Switzerland, and Luxembourg.

Anna Tucker, director of EMEA distributor sales for Congenica, reiterated in a statement that the company is actively looking to expand into new markets as well as new medical indications. "By signing this distribution agreement, we are able to support the rapidly growing genomics market in France," Tucker added.

"We believe that Congenica's software has the potential to transform the genomic analysis capabilities of research institutions, diagnostic laboratories, and hospitals throughout France," said AmpliTech General Manager Gilles Cestelli. "With the French genomics market growing rapidly, we envisage a future where genomic medicine can be incorporated into standard clinical practice, enabled by Congenica."

The Scan

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.